17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effects of exogenous lactate on lipid, protein, and glucose metabolism—a randomized crossover trial in healthy males

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Abstract

          Lactate may inhibit lipolysis and thus enhance insulin sensitivity, but there is a lack of metabolic human studies. This study aimed to determine how hyperlactatemia affects lipolysis, glucose- and protein metabolism, and insulin sensitivity in healthy men. In a single-blind, randomized, crossover design, eight healthy men were studied after an overnight fast on two occasions: 1) during a sodium-lactate infusion (LAC) and 2) during a sodium-matched NaCl infusion (CTR). Both days consisted of a 3-h postabsorptive period followed by a 3-h hyperinsulinemic-euglycemic clamp (HEC). Lipolysis rate, endogenous glucose production (EGP), and delta glucose rate of disappearance (ΔRd glu) were evaluated using [9,10- 3H]palmitate and [3- 3H]glucose tracers. In addition, whole body- and forearm protein metabolism was assessed using [ 15N]phenylalanine, [ 2H 4]tyrosine, [ 15N]tyrosine, and [ 13C]urea tracers. In the postabsorptive period, plasma lactate increased to 2.7 ± 0.5 mmol/L during LAC vs. 0.6 ± 0.3 mmol/L during CTR ( P < 0.001). In the postabsorptive period, palmitate flux was 30% lower during LAC compared with CTR (84 ± 32 µmol/min vs. 120 ± 35 µmol/min, P = 0.003). During the HEC, palmitate flux was suppressed similarly during both interventions ( P = 0.7). EGP, ΔRd glu, and M value were similar during LAC and CTR. During HEC, LAC increased whole body phenylalanine flux ( P = 0.02) and protein synthesis ( P = 0.03) compared with CTR; LAC did not affect forearm protein metabolism compared with CTR. Lactate infusion inhibited lipolysis by 30% under postabsorptive conditions but did not affect glucose metabolism or improve insulin sensitivity. In addition, whole body phenylalanine flux was increased. Clinical trial registrations: NCT04710875.

          NEW & NOTEWORTHY Lactate is a decisive intermediary metabolite, serving as an energy substrate and a signaling molecule. The present study examines the effects of lactate on substrate metabolism and insulin sensitivity in healthy males. Hyperlactatemia reduces lipolysis by 30% without affecting insulin sensitivity and glucose metabolism. In addition, hyperlactatemia increases whole body amino acid turnover rate.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: found
          • Article: not found

          Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81.

          Lactic acid is a well known metabolic by-product of intense exercise, particularly under anaerobic conditions. Lactate is also a key source of energy and an important metabolic substrate, and it has also been hypothesized to be a signaling molecule directing metabolic activity. Here we show that GPR81, an orphan G-protein-coupled receptor highly expressed in fat, is in fact a sensor for lactate. Lactate activates GPR81 in its physiological concentration range of 1-20 mM and suppresses lipolysis in mouse, rat, and human adipocytes as well as in differentiated 3T3-L1 cells. Adipocytes from GPR81-deficient mice lack an antilipolytic response to lactate but are responsive to other antilipolytic agents. Lactate specifically induces internalization of GPR81 after receptor activation. Site-directed mutagenesis of GPR81 coupled with homology modeling demonstrates that classically conserved key residues in the transmembrane binding domains are responsible for interacting with lactate. Our results indicate that lactate suppresses lipolysis in adipose tissue through a direct activation of GPR81. GPR81 may thus be an attractive target for the treatment of dyslipidemia and other metabolic disorders.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81.

            Lactate is an important metabolic intermediate released by skeletal muscle and other organs including the adipose tissue, which converts glucose into lactate under the influence of insulin. Here we show that lactate activates the G protein-coupled receptor GPR81, which is expressed in adipocytes and mediates antilipolytic effects through G(i)-dependent inhibition of adenylyl cyclase. Using GPR81-deficient mice, we demonstrate that the receptor is not involved in the regulation of lipolysis during intensive exercise. However, insulin-induced inhibition of lipolysis and insulin-induced decrease in adipocyte cAMP levels were strongly reduced in mice lacking GPR81, although insulin-dependent release of lactate by adipocytes was comparable between wild-type and GPR81-deficient mice. Thus, lactate and its receptor GPR81 unexpectedly function in an autocrine and paracrine loop to mediate insulin-induced antilipolytic effects. These data show that lactate can directly modulate metabolic processes in a hormone-like manner, and they reveal a new mechanism underlying the antilipolytic effects of insulin. 2010 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Role of GPR81 in lactate-mediated reduction of adipose lipolysis.

              Heavy exercise or oxygen deficit often links with higher levels of arterial lactate and lower levels of plasma free fatty acids (FFA). Treatment with lactate reduces circulating levels of FFA in vivo and lipolysis in adipose tissues in vitro. However, the underlying mechanism has remained unclear. Here we employ pharmacological and genetic approaches to show that GPR81, an orphan G-protein-coupled receptor with relatively restricted expression in the adipose tissues, functions as a receptor for lactate and can mediate an anti-lipolytic effect of lactate. GPR81 may thus function as a sensor of lactate that can modulate the FFA pool under exercise or conditions of oxygen deficit.
                Bookmark

                Author and article information

                Journal
                Am J Physiol Endocrinol Metab
                Am J Physiol Endocrinol Metab
                AJPENDO
                American Journal of Physiology - Endocrinology and Metabolism
                American Physiological Society (Rockville, MD )
                0193-1849
                1522-1555
                1 April 2024
                7 February 2024
                7 February 2024
                : 326
                : 4
                : E443-E453
                Affiliations
                [1] 1Steno Diabetes Center Aarhus, Aarhus University Hospital , Aarhus, Denmark
                [2] 2Medical Research Laboratory, Aarhus University , Aarhus, Denmark
                [3] 3Department of Cardiology, Aarhus University Hospital , Aarhus, Denmark
                [4] 4Department of Nuclear Medicine & PET Centre, Aarhus University Hospital , Aarhus, Denmark
                Author notes
                Correspondence: M. G. B. Pedersen ( metteglavind@ 123456clin.au.dk ).
                Author information
                https://orcid.org/0000-0003-3670-941X
                https://orcid.org/0000-0001-9938-2181
                https://orcid.org/0000-0002-0144-1305
                https://orcid.org/0000-0001-8041-6994
                Article
                E-00301-2023 E-00301-2023
                10.1152/ajpendo.00301.2023
                11193511
                38324259
                4e36dd11-6da1-4646-a434-30eaa7e89803
                The Authors.

                Licensed under Creative Commons Attribution CC-BY 4.0. Published by the American Physiological Society.

                History
                : 12 September 2023
                : 18 January 2024
                : 1 February 2024
                Funding
                Funded by: Novo Nordisk Fonden (NNF), doi 10.13039/501100009708;
                Award ID: NNF19OC0055002
                Award Recipient : Niels Møller
                Categories
                Research Article
                clinical-metabolism
                Clinical Metabolism
                Custom metadata
                True

                Endocrinology & Diabetes
                energy expenditure,insulin sensitivity,lactate,lipolysis,protein metabolism

                Comments

                Comment on this article